Alternative Access First Priority CLO Bond ETF (AAA)
Live price chart, market sentiment, and community perspectives for Alternative Access First Priority CLO Bond ETF (AMEX: AAA).
Live price chart, market sentiment, and community perspectives for Alternative Access First Priority CLO Bond ETF (AMEX: AAA).
On our desk, we are heavily evaluating the risk profile of the Alternative Access First Priority CLO Bond ETF (AAA). Over a five-year window, the fund maintained an exceptionally low beta of 0.06 compared to the benchmark's 1.08 and captured only -22% of downside moves. Even during the 2022 rate shock, its worst drawdown was a minimal -2.1%, making it an ideal defensive sleeve for conservative portfolios.
When analyzing the structural mechanics of AAA, our quant team notes that it pools hundreds of floating-rate corporate loans into ranked tranches. Because the underlying loans carry floating rates tied to SOFR, the fund's income adjusts dynamically with short-term rate movements rather than locking investors into a fixed coupon, eliminating duration risk effectively.
Watching the macro sentiment unfold, retirees and fixed-income allocators are quietly targeting a 5% yield with almost zero price swings through AAA. As VettaFi's research highlights, ongoing rate uncertainty and the Fed's decisions to keep rates unchanged are acting as massive catalysts for short-term product demand in floating-rate secured loan strategies.
From a risk manager's perspective, the fund's 5-year standard deviation sits at 1.4%, and its Sharpe ratio of 0.72 easily beats the category median of 0.08. When benchmarking against peers like the Janus Henderson AAA CLO ETF (JAAA), iShares AAA CLO Active ETF (CLOA), and VanEck CLO ETF, AAA consistently demonstrates superior capital preservation and efficiency.
As a hedge fund PM looking at alternative fixed-income products, the demand for CLO exposure is surging due to persistent rate uncertainty. The fund focuses exclusively on the senior-most slice of Collateralized Loan Obligations—the AAA tranche that sits first in line for repayment before any losses can ever reach investors.
Explore plasma cleansing, somatic organ swaps, and BCI.